Aligos Therapeutics, Inc. - Common stock (ALGS) SEC filings

ALGS SEC filings moved a median of +0.19% by the close. ALGS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ALGS overview →

69 measured ALGS SEC filing events.

Where these ALGS SEC filings landedvs 69 measured ALGS SEC filing reactions
ALGS SEC filingMiddle 50% · -2.06% to +5.17%Zero: 0.00%Median: +0.19%Median +0.19%-8.00%0+8.00%
Middle 50% of ALGS SEC filing reactions-2.06% to +5.17%
Median reaction (to close)+0.19%
Measured reactions69
Point-in-time · zero look-ahead

Half of the 69 ALGS SEC filing events with a measured close landed between -2.06% and +5.17%; 54% closed up.

DateHeadlineEvent5-minTo close
Form 8-K Aligos Therapeutics, For: Sep 10SEC filing · Form 8-K+0.20%+0.80%
Form 10-Q Aligos Therapeutics, For: Jun 30SEC filing · Form 10-Q+2.87%+31.82%
Form 8-K Aligos Therapeutics, For: Aug 06SEC filing · Form 8-K+2.87%+31.82%
Form S-8 Aligos Therapeutics,SEC filing · Form S-8+0.82%+1.64%
Form 8-K Aligos Therapeutics, For: Jun 25SEC filing · Form 8-K+0.00%-1.81%
Form 10-Q Aligos Therapeutics, For: Mar 31SEC filing · Form 10-Q-2.46%+5.40%
Form 8-K Aligos Therapeutics, For: May 07SEC filing · Form 8-K-2.46%+5.40%
Form ARS Aligos Therapeutics, For: Dec 31SEC filing · Form ARS+3.83%-0.17%
Form DEF 14A Aligos Therapeutics, For: Jun 25SEC filing · Form DEF+3.83%-0.17%
Form DEFA14A Aligos Therapeutics,SEC filing · Form DEFA14A+3.83%-0.17%
Form 8-K Aligos Therapeutics, For: Apr 16SEC filing · Form 8-K-1.68%-0.61%
Form 8-K Aligos Therapeutics, For: Apr 14SEC filing · Form 8-K+4.78%-1.59%
Form 10-K Aligos Therapeutics, For: Dec 31SEC filing · Form 10-K+0.00%-2.06%
Form 8-K Aligos Therapeutics, For: Mar 05SEC filing · Form 8-K+0.00%-2.06%
Form S-8 Aligos Therapeutics,SEC filing · Form S-8+0.00%-2.06%
Form 8-K Aligos Therapeutics, For: Jan 29SEC filing · Form 8-K+0.00%-7.55%
Form 10-Q Aligos Therapeutics, For: Sep 30SEC filing · Form 10-Q-8.27%+3.20%
Form 8-K Aligos Therapeutics, For: Nov 06SEC filing · Form 8-K-8.27%+3.20%
Form 10-Q Aligos Therapeutics, For: Jun 30SEC filing · Form 10-Q+1.33%+5.17%
Form 8-K Aligos Therapeutics, For: Aug 06SEC filing · Form 8-K+1.33%+5.17%
Form S-8 Aligos Therapeutics,SEC filing · Form S-8+1.33%+5.17%
Form 8-K Aligos Therapeutics, For: Jun 25SEC filing · Form 8-K+4.34%+0.84%
Form 10-Q Aligos Therapeutics, For: Mar 31SEC filing · Form 10-Q-3.00%-15.03%
Form 8-K Aligos Therapeutics, For: May 06SEC filing · Form 8-K-3.00%-15.03%
Form ARS Aligos Therapeutics, For: Dec 31SEC filing · Form ARS-0.19%+0.19%
Form DEF 14A Aligos Therapeutics, For: Jun 25SEC filing · Form DEF-0.19%+0.19%
Form DEFA14A Aligos Therapeutics,SEC filing · Form DEFA14A-0.19%+0.19%
Form PRE 14A Aligos Therapeutics, For: Jun 25SEC filing · Form PRE+0.54%+1.52%
Form EFFECT Aligos Therapeutics,SEC filing · Form EFFECT-2.95%-2.46%
Form S-3 Aligos Therapeutics,SEC filing · Form S-3-3.15%-4.30%
Form 10-K Aligos Therapeutics, For: Dec 31SEC filing · Form 10-K-1.32%-14.39%
Form 8-K Aligos Therapeutics, For: Mar 10SEC filing · Form 8-K-1.32%-14.39%
Form S-8 Aligos Therapeutics,SEC filing · Form S-8+0.19%+2.04%
Form D Aligos Therapeutics,SEC filing · Form D-0.65%-15.60%
Form 8-K Aligos Therapeutics, For: Feb 11SEC filing · Form 8-K-6.38%-17.74%
Form 8-K Aligos Therapeutics, For: Jan 30SEC filing · Form 8-K+2.35%+13.13%
Form EFFECT Aligos Therapeutics,SEC filing · Form EFFECT-1.75%-6.52%
Form 10-Q Aligos Therapeutics, For: Sep 30SEC filing · Form 10-Q+1.70%+9.25%
Form 8-K Aligos Therapeutics, For: Nov 06SEC filing · Form 8-K+1.70%+9.25%
Form S-3 Aligos Therapeutics,SEC filing · Form S-3+1.70%+9.25%
Form S-8 Aligos Therapeutics,SEC filing · Form S-8+1.70%+9.25%
Form 8-K Aligos Therapeutics, For: Sep 03SEC filing · Form 8-K—+6.20%
Form 8-K Aligos Therapeutics, For: Aug 14SEC filing · Form 8-K+0.63%+1.83%
Form 8-K Aligos Therapeutics, For: Aug 07SEC filing · Form 8-K+0.00%+0.00%
Form 10-Q Aligos Therapeutics, For: Jun 30SEC filing · Form 10-Q+3.27%+17.28%
Form 8-K Aligos Therapeutics, For: Aug 06SEC filing · Form 8-K+3.27%+17.28%
Form 8-K Aligos Therapeutics, For: Jun 27SEC filing · Form 8-K+2.16%+5.43%
Form 8-K Aligos Therapeutics, For: May 29SEC filing · Form 8-K+0.00%+1.10%
Form 8-K Aligos Therapeutics, For: May 21SEC filing · Form 8-K+1.69%-7.69%
Form 8-K Aligos Therapeutics, For: May 09SEC filing · Form 8-K+1.36%-5.07%
Form 10-Q Aligos Therapeutics, For: Mar 31SEC filing · Form 10-Q+4.43%-0.26%
Form 8-K Aligos Therapeutics, For: May 07SEC filing · Form 8-K+4.43%-0.26%
Form ARS Aligos Therapeutics, For: Dec 31SEC filing · Form ARS+6.32%+3.10%
Form DEF 14A Aligos Therapeutics, For: Jun 27SEC filing · Form DEF+6.32%+3.10%
Form DEFA14A Aligos Therapeutics,SEC filing · Form DEFA14A+6.32%+3.10%
Form PRE 14A Aligos Therapeutics, For: Jun 27SEC filing · Form PRE+4.24%-2.96%
Form 10-K Aligos Therapeutics, For: Dec 31SEC filing · Form 10-K-4.48%+0.00%
Form 8-K Aligos Therapeutics, For: Mar 12SEC filing · Form 8-K-4.48%+0.00%
Form S-8 Aligos Therapeutics,SEC filing · Form S-8-4.48%+0.00%
Form 8-K Aligos Therapeutics, For: Feb 27SEC filing · Form 8-K-1.55%+3.13%
Form 8-K Aligos Therapeutics, For: Jan 25SEC filing · Form 8-K-2.53%-1.12%
Form EFFECT Aligos Therapeutics,SEC filing · Form EFFECT+0.00%-1.41%
Form 8-K Aligos Therapeutics, For: Nov 20SEC filing · Form 8-K—+8.01%
Form S-3 Aligos Therapeutics,SEC filing · Form S-3+3.85%+10.43%
Form 8-K Aligos Therapeutics, For: Nov 09SEC filing · Form 8-K+0.00%-4.31%
Form D Aligos Therapeutics,SEC filing · Form D—-5.64%
Form 10-Q Aligos Therapeutics, For: Sep 30SEC filing · Form 10-Q-2.67%+1.36%
Form 8-K Aligos Therapeutics, For: Nov 02SEC filing · Form 8-K-2.67%+1.36%
Form 8-K Aligos Therapeutics, For: Oct 23SEC filing · Form 8-K+0.13%+4.92%
That’s how ALGS usually reacts to SEC filings — get an email when it moves on news →
Keep exploring

More ALGS: earnings → · analyst actions → · ALGS overview →